Galectin Therapeutics (GALT) Net Income Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,228.66% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 37.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.24% |
| Dec 31, 2025 | 62.48% |
| Sep 30, 2025 | 42.88% |
| Jun 30, 2025 | 48.52% |
| Mar 31, 2025 | 9.55% |
| Dec 31, 2024 | -36.14% |
| Sep 30, 2024 | -5.31% |
| Jun 30, 2024 | -29.96% |
| Mar 31, 2024 | 1.28% |
| Dec 31, 2023 | 5.29% |
| Sep 30, 2023 | -18.70% |
| Jun 30, 2023 | 2.88% |
| Mar 31, 2023 | -5.88% |
| Dec 31, 2022 | -41.76% |
| Sep 30, 2022 | -1.49% |
| Jun 30, 2022 | -19.46% |
| Mar 31, 2022 | -60.32% |
| Dec 31, 2021 | 1.97% |
| Sep 30, 2021 | -38.82% |
| Jun 30, 2021 | -35.38% |
| Mar 31, 2021 | -78.23% |
| Dec 31, 2020 | -52.85% |
| Sep 30, 2020 | -113.47% |
| Jun 30, 2020 | -103.94% |
| Mar 31, 2020 | -49.73% |
| Dec 31, 2019 | -68.43% |
| Sep 30, 2019 | -1.16% |
| Jun 30, 2019 | 21.93% |
| Mar 31, 2019 | 44.22% |
| Dec 31, 2018 | -28.69% |
| Sep 30, 2018 | 37.57% |
| Jun 30, 2018 | 14.82% |
| Mar 31, 2018 | 13.75% |
| Dec 31, 2017 | 48.38% |
| Sep 30, 2017 | 2.61% |
| Jun 30, 2017 | 18.32% |
| Mar 31, 2017 | 27.40% |
| Dec 31, 2016 | 1.71% |
| Sep 30, 2016 | 23.12% |
| Jun 30, 2016 | -18.87% |
| Mar 31, 2016 | -40.90% |
| Dec 31, 2015 | -25.53% |
| Sep 30, 2015 | -69.90% |
| Jun 30, 2015 | -38.10% |
| Mar 31, 2015 | 0.29% |
| Dec 31, 2014 | -32.94% |
| Sep 30, 2014 | 2.17% |
| Jun 30, 2014 | -32.15% |
| Mar 31, 2014 | -51.11% |
| Dec 31, 2013 | -17.80% |
| Sep 30, 2013 | -22.60% |
| Jun 30, 2013 | 4.36% |
| Mar 31, 2013 | -64.26% |
| Dec 31, 2012 | 29.45% |
| Sep 30, 2012 | -42.46% |
| Jun 30, 2012 | 10.95% |
| Mar 31, 2012 | 2.89% |
| Dec 31, 2011 | -161.69% |
| Sep 30, 2011 | -67.74% |
| Jun 30, 2011 | -121.42% |